Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 1983 Aug;47(2):77-83.
doi: 10.1007/BF02482641.

Lymphocyte characteristics and function in paroxysmal nocturnal haemoglobinuria

Lymphocyte characteristics and function in paroxysmal nocturnal haemoglobinuria

E Vellenga et al. Blut. 1983 Aug.

Abstract

In six patients with paroxysmal nocturnal haemoglobinuria (PNH) lymphocyte studies were performed to investigate whether the observed immunological dysfunction could be ascribed to a defect in lymphocytes as result of the PNH characteristics, or to an imbalance between T-cell subsets. The PNH characteristics were studied by means of the effect of serum and acidified serum on Indium111-oxine labelled lymphocytes. No increase in release of Indium111-oxine was found when lymphocytes were exposed to acidified sera. Thus a complement mediated lymphocyte lysis in PNH could not be demonstrated. T-cells were defined by monoclonal antibodies, directed at total T-cells (OKT3), helper T cells (OKT4) and suppressor/cytotoxic T-cells (OKT8). In two of the six patients a decreased proportion of OKT3 cells was found, while a significantly depressed ratio of OKT4/OKT8 cells was present in the whole group. No obvious correlation was found between a functional assay - the concanavalin-A suppressor cell activity - and the ratio of OKT4/OKT8 positive cells. It is concluded that the PNH characteristics could not be demonstrated in the lymphocytes; and that the immunological dysregulation in PNH may be ascribed to an imbalance of T-cell subsets, while a decreased number of monocytes, defined by the monoclonal antibody OKM1, may contribute to this defect.

PubMed Disclaimer

Similar articles

References

    1. Blood. 1982 Jul;60(1):157-9 - PubMed
    1. J Immunol. 1976 Jan;116(1):131-9 - PubMed
    1. J Clin Invest. 1973 May;52(5):1129-37 - PubMed
    1. J Clin Invest. 1982 Sep;70(3):619-26 - PubMed
    1. J Clin Invest. 1969 Jul;48(7):1199-210 - PubMed

MeSH terms